Artificial intelligence to unlock real‐world evidence in clinical oncology: A primer on recent advances
Cancer Medicine · 2024-06 · 13 (12)
DOI: 10.1002/cam4.7253 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 20.06.2024. Verfasst von Alex K Bryant und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Medical Oncology, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Veterans Affairs, NCI NIH HHS, LUNGevity Foundation.
Abstract (Originalsprache)
Purpose
Real world evidence is crucial to understanding the diffusion of new oncologic therapies, monitoring cancer outcomes, and detecting unexpected toxicities. In practice, real world evidence is challenging to collect rapidly and comprehensively, often requiring expensive and time‐consuming manual case‐finding and annotation of clinical text. In this Review, we summarise recent developments in the use of artificial intelligence to collect and analyze real world evidence in oncology.
Methods
We performed a narrative review of the major current trends and recent literature in artificial intelligence applications in oncology.
Results
Artificial intelligence (AI) approaches are increasingly used to efficiently phenotype patients and tumors at large scale. These tools also may provide novel biological insights and improve risk prediction through multimodal integration of radiographic, pathological, and genomic datasets. Custom language processing pipelines and large language models hold great promise for clinical prediction and phenotyping.
Conclusions
Despite rapid advances, continued progress in computation, generalizability, interpretability, and reliability as well as prospective validation are needed to integrate AI approaches into routine clinical care and real‐time monitoring of novel therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
- Department of Radiation Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.
- Applied Mathematics and Computational Research Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA.
- Computational Science Initiative, Brookhaven National Laboratory, Upton, New York, USA.
- Department of Pharmacology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
- Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
ORCID-Profile: Alex K Bryant, Michael D Green
Förderung
- Veterans Affairs
- NCI NIH HHS
- LUNGevity Foundation
- BLRD VA
- Melanoma Research Alliance
- U.S. Department of Veterans Affairs
Zitieren
APA
Bryant, A. K., Zamora-Resendiz, R., Dai, X., Morrow, D., Lin, Y., Jungles, K. M., Rae, J. M., Tate, A., Pearson, A. N., Jiang, R., Fritsche, L., Lawrence, T. S., Zou, W., Schipper, M., Ramnath, N., Yoo, S., Crivelli, S., & Green, M. D. (2024). Artificial intelligence to unlock real‐world evidence in clinical oncology: A primer on recent advances. Cancer Medicine, 13(12). https://doi.org/10.1002/cam4.7253
Vancouver
Bryant AK, Zamora-Resendiz R, Dai X, Morrow D, Lin Y, Jungles KM, et al. Artificial intelligence to unlock real‐world evidence in clinical oncology: A primer on recent advances. Cancer Medicine. 2024;13(12). doi:10.1002/cam4.7253
BibTeX
@article{Bryant2024,
author = {Bryant, Alex K and Zamora-Resendiz, Rafael and Dai, Xin and Morrow, Destinee and Lin, Yuewei and Jungles, Kassidy M and Rae, James M and Tate, Akshay and Pearson, Ashley N and Jiang, Ralph and Fritsche, Lars and Lawrence, Theodore S and Zou, Weiping and Schipper, Matthew and Ramnath, Nithya and Yoo, Shinjae and Crivelli, Silvia and Green, Michael D},
title = {Artificial intelligence to unlock real‐world evidence in clinical oncology: A primer on recent advances},
journal = {Cancer Medicine},
year = {2024},
volume = {13},
number = {12},
doi = {10.1002/cam4.7253}
}
EUVIMED